Cart
sales@molnova.com
WDR5 WIN site inhibitor C6
CAS No. ——
WDR5 WIN site inhibitor C6( —— )
Catalog No. M17068 CAS No. ——
WDR5 WIN site inhibitor C6 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 0.1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameWDR5 WIN site inhibitor C6
-
NoteResearch use only, not for human use.
-
Brief DescriptionWDR5 WIN site inhibitor C6 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 0.1 nM.
-
DescriptionWDR5 WIN site inhibitor C6 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 0.1 nM; inhibits leukemia cell lines in vitro (MV4:11 cell GI50=3.2 uM), rapidly displace WDR5 from chromatin and decrease the expression of associated genes, causing translational inhibition, nucleolar stress, and p53 induction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight498.383
-
Molecular FormulaC25H22Cl2FN5O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-(3,4-dichlorobenzyl)-3-(6-fluoro-2-methylpyridin-3-yl)-5-((2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl)methyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Aho ER, et al. Cell Rep. 2019 Mar 12;26(11):2916-2928.e13.
molnova catalog
related products
-
CM-579
CM-579 (CM579) is a novel potent, selective and reversible dual inhibitor of G9a/DNMTs with IC50 of 16 nM and 32 nM for G9a and DNMT1, respectively.
-
MI-2-2 hydrochloride
MI-2-2 hydrochloride is a potent inhibitor of the menin-MLL interaction that binds to menin with low nanomolar affinity (Kd=22 nM).
-
PF-06726304
PF-06726304 is a novel potent enhancer of zeste homolog 2 (EZH2) inhibitor.
